BLBD Form 4: Director Phil Horlock Reports 30,000-Share Sale on 08/08/2025

Rhea-AI Filing Summary

Phil Horlock, a director of Blue Bird Corporation (BLBD), reported a sale of company common stock on 08/08/2025. The Form 4 shows a transaction coded as a sale of 30,000 shares at a price shown as $60 per share, leaving the reporting person with 240,766 shares beneficially owned after the transaction. The Form 4 was signed by an attorney-in-fact, Matthew Meziere, on 08/11/2025.

Positive

• Clear quantitative disclosure of shares sold (30,000) and post-transaction beneficial ownership (240,766)
• Form 4 filed and signed (attorney-in-fact signature dated 08/11/2025), providing official Section 16 disclosure

Negative

• Insider sale of 30,000 shares by a director, which reduces insider ownership
• No 10b5-1 plan indicated on this Form 4 (no checkbox marked to show a prearranged trading plan)

Insights

Securities Analyst

TL;DR: Director sale of 30,000 BLBD shares reported; remaining beneficial ownership 240,766 shares.

The filing documents a direct sale by director Phil Horlock on 08/08/2025 of 30,000 common shares at a price recorded as $60, resulting in reported beneficial ownership of 240,766 shares. The disclosure is routine Section 16 reporting and provides clear, quantified detail on the change in insider holdings; no derivative or additional compensatory transactions are reported in this Form 4.

Corporate Governance Expert

TL;DR: Routine insider sale disclosed; documentation signed by attorney-in-fact on 08/11/2025.

The Form 4 identifies Phil Horlock as the reporting person and director, and it records a sale transaction on 08/08/2025. The form was executed by an attorney-in-fact, Matthew Meziere, on 08/11/2025. From a governance standpoint, the filing provides the necessary transactional detail but does not indicate any 10b5-1 plan or derivative activity on this form.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Horlock Phil

(Last) (First) (Middle)

3920 ARKWRIGHT ROAD

SUITE 200

(Street)

MACON GA 31210

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Blue Bird Corp [ BLBD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/08/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.0001 per share	08/08/2025		S		30,000	D	$60	240,766	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Matthew Meziere as attorney-in-fact	08/11/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who filed the Form 4 for Blue Bird Corporation (BLBD)?

The reporting person is Phil Horlock, identified as a director of Blue Bird Corporation.

What transaction was reported on the BLBD Form 4?

A sale of 30,000 common shares on 08/08/2025 at a price shown as $60 per share.

How many BLBD shares did the reporting person own after the transaction?

The Form 4 reports 240,766 shares beneficially owned following the reported transaction.

Was the Form 4 signed and when?

The form was signed by attorney-in-fact Matthew Meziere on 08/11/2025.

Does the Form 4 indicate the sale was under a 10b5-1 trading plan?

The Form 4 does not indicate a 10b5-1 trading plan (no checkbox marked to show such a plan).